NCT03233711 2026-03-18
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
13 trialsNCT04929028 2026-03-18
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT05419011 2026-03-18
Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT05630794 2026-03-18
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
National Cancer Institute (NCI)
Phase 1 Recruiting
NCT07472868 2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3 Not yet recruiting
NCT00748449 2026-03-06
COLO-TDM
Assistance Publique - Hôpitaux de Paris
Phase NA Terminated
NCT05976763 2026-03-04
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT07090291 2026-03-04
China Colorectal Cancer Screening Trial 1 (C-Cost1)
Zhejiang University
Phase NA Recruiting
NCT07361575 2026-02-17
POG
Clinique Paris-Bercy
Phase NA Not yet recruiting
NCT07360834 2026-01-23
PREDI-LYNCH
UNICANCER
Phase NA Not yet recruiting
NCT04767984 2026-01-21
Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis
Northwestern University
Phase 2 Active not recruiting
NCT05643859 2026-01-15
Impact of Dietary Fiber Supplementation on Colonic Microbiome
OHSU Knight Cancer Institute
Phase NA Recruiting
NCT06983639 2026-01-15
FIT
Sorlandet Hospital HF
Phase NA Recruiting